We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.32B
AUM Growth
+$316M
Cap. Flow
-$173M
Cap. Flow %
-4%
Top 10 Hldgs %
10.31%
Holding
2,841
New
651
Increased
541
Reduced
445
Closed
892

Sector Composition

Rank Sector Weight
1 Financials 12.96%
2 Healthcare 8.24%
3 Technology 8.23%
4 Industrials 6.13%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
1826
Lumen
LUMN
$6.09B
$54K ﹤0.01%
10,340
-8,860
-46% -$54.5K
HTCO
1827
High-Trend International Group
HTCO
$30.4M
$53K ﹤0.01%
+1,669
New +$72.1K
GBBKR
1828
DELISTED
Global Blockchain Acquisition Corp. Right
GBBKR
$52.9K ﹤0.01%
772,944
+22,944
+3% +$1.46K
JWACR
1829
DELISTED
Jupiter Wellness Acquisition Corp. Right
JWACR
$52.5K ﹤0.01%
700,000
AUTL
1830
Autolus Therapeutics
AUTL
$532M
$51.7K ﹤0.01%
27,215
BBBY
1831
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
$51.5K ﹤0.01%
+20,500
New +$80.5K
FLEX icon
1832
CALL
Flex
FLEX
$45.3B
$51.2K ﹤0.01%
24,682
TARA icon
1833
Protara Therapeutics
TARA
$230M
$50.6K ﹤0.01%
18,864
ELDN icon
1834
Eledon Pharmaceuticals
ELDN
$267M
$50.3K ﹤0.01%
22,050
BARK icon
1835
BARK
BARK
$82.7M
$50K ﹤0.01%
+1,679
New +$55.9K
RZLT icon
1836
Rezolute
RZLT
$453M
$49.7K ﹤0.01%
24,000
MBTCR
1837
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$46.3K ﹤0.01%
595,265
ALSAR
1838
DELISTED
Alpha Star Acquisition Corp Rights
ALSAR
$45K ﹤0.01%
360,200
BNR
1839
Burning Rock Biotech
BNR
$93.7M
$44.8K ﹤0.01%
+1,990
New +$45.4K
RLMD icon
1840
Relmada Therapeutics
RLMD
$564M
$44.6K ﹤0.01%
+12,792
New +$112K
ATAKR
1841
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$43.5K ﹤0.01%
335,000
-250,000
-43% -$18.8K
BRLT icon
1842
Brilliant Earth
BRLT
$19.7M
$43.1K ﹤0.01%
+10,000
New +$59.9K
NOVVR
1843
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$42.9K ﹤0.01%
485,000
WINVR
1844
DELISTED
WinVest Acquisition Corp. Right
WINVR
$42.8K ﹤0.01%
590,000
CNVS icon
1845
Cineverse
CNVS
$62.3M
$42.6K ﹤0.01%
+5,500
New +$52.4K
DNA icon
1846
Ginkgo Bioworks
DNA
$555M
$42.3K ﹤0.01%
+625
New +$57.5K
ANEB
1847
DELISTED
Anebulo Pharmaceuticals
ANEB
$42K ﹤0.01%
17,319
GBRGR
1848
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
$40.3K ﹤0.01%
310,317
KPRX icon
1849
Kiora Pharmaceuticals
KPRX
$11.3M
$40.1K ﹤0.01%
+1,298
New +$59.8K
CSLMR
1850
DELISTED
CSLM Acquisition Corp. Right
CSLMR
$39.3K ﹤0.01%
560,000

Similar funds

Boothbay Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boothbay Fund Management held 2,841 positions worth $4.32B, up 7.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q4 2022, closing 892 positions and reducing 445 holdings. Its most notable exit was Alleghany Corp, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Kairos Acquisition Corp. Class A Ordinary Shares worth $12.6M.

  • Boothbay Fund Management's largest Q4 2022 buy was Kairos Acquisition Corp. Class A Ordinary Shares: 1,255,444 shares worth $12.6M.
  • Boothbay Fund Management added most to RMG Acquisition Corp. III Class A Ordinary Shares in Q4 2022, an estimated $19.5M increase.
  • Boothbay Fund Management's biggest Q4 2022 reduction was ADMA Biologics, cutting an estimated $21.8M.
  • Boothbay Fund Management fully exited Alleghany Corp in Q4 2022, selling an estimated $20.1M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $4.32B portfolio in Q4 2022.
  • Boothbay Fund Management opened 651 new positions and closed 892 in Q4 2022.
  • Boothbay Fund Management's portfolio value rose 7.9% quarter-over-quarter to $4.32B.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.